Novartis eyes $1B Lutathera acceleration with first-line win
19 Jan 2024 //
FIERCE PHARMA
Bicycle signs on new clinical execs in pipeline drive
10 May 2019 //
ENDPTS
Novartis exploring Saudi Arabia for production of cancer drugs
10 May 2019 //
FIERCE PHARMA
Did Novartis game Europe`s orphan program to overprice Lutathera?
15 Jan 2019 //
FIERCE PHARMA